Clinical trial
Determination of The 90% Effective Dose of Tegileridine Combined With Propofol for Gastroscopy in Patients of Different Ages: A Biased-Coin Up-and-down Design Study
NCT07678411 is registered in ClinicalTrials.gov with Shiyou Wei as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of The 90% Effective Dose of Tegileridine Combined With Propofol for Gastroscopy in Patients of Different Ages: A Biased-Coin Up-and-down Design Study
- Lead sponsor
- Shiyou Wei
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 1, 2026
- Completion date
- July 24, 2026
- Enrollment
- 107 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
painless gastroscopy perioperative sedation, upper gastrointestinal tract lesions